Lithium-Induced Hyperparathyroidism: An Ill-defined Territory
Lithium is the gold standard treatment for bipolar disorder. Studies have shown an association between lithium and hyperparathyroidism. However, there is limited data regarding the management of lithium-induced hyperparathyroidism. We present a clinical conundrum which physicians frequently encounter-an excellent lithium responder refractory to other treatments who developed lithium-induced hyperparathyroidism. Medical treatment with cinacalcet was successful in management of hyperparathyroidism without discontinuing lithium maintenance therapy.
Authors
- Chaitra Gopinath (ORCID: https://orcid.org/0000-0002-7029-3641)
- Vishnu Sundaresh (ORCID: https://orcid.org/0000-0003-2368-2342)
- Balwinder Singh (ORCID: https://orcid.org/0000-0001-7062-8192)
- Sahar S. Abdelmoneim (ORCID: https://orcid.org/0000-0003-0995-8795)
- Vishwanath Pattan (ORCID: https://orcid.org/0000-0002-7077-8331)
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4410
- Citations
- 9
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00